1. Home
  2. IDCC vs PTCT Comparison

IDCC vs PTCT Comparison

Compare IDCC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

HOLD

Current Price

$258.21

Market Cap

6.5B

Sector

Miscellaneous

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$70.47

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDCC
PTCT
Founded
1972
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.7B
IPO Year
2007
2006

Fundamental Metrics

Financial Performance
Metric
IDCC
PTCT
Price
$258.21
$70.47
Analyst Decision
Strong Buy
Buy
Analyst Count
2
17
Target Price
$412.50
$80.65
AVG Volume (30 Days)
271.3K
1.3M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
264.48
EPS
2.14
N/A
Revenue
$307,404,000.00
$264,734,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.38
$17.70
P/E Ratio
$122.06
N/A
Revenue Growth
N/A
36.19
52 Week Low
$213.06
$43.18
52 Week High
$412.60
$87.50

Technical Indicators

Market Signals
Indicator
IDCC
PTCT
Relative Strength Index (RSI) 36.12 50.56
Support Level $252.50 $68.49
Resistance Level $363.73 $73.17
Average True Range (ATR) 7.60 2.40
MACD 2.67 -0.13
Stochastic Oscillator 46.00 47.16

Price Performance

Historical Comparison
IDCC
PTCT

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: